Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for TRxADE HEALTH, Inc. (MEDS : NSDQ)

• Company Description    TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group Inc., is based in TAMPA, FL. Number of Employees: 47

• Price / Volume Information    Yesterday's Closing Price: $1.46 Daily Weekly Monthly 20 Day Moving Average: 28,092 shares Shares Outstanding: 8.18 (millions) Market Capitalization: $11.94 (millions) Beta: 1.36 52 Week High: $9.49 52 Week Low: $1.16 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -26.26% -16.19% 12 Week -21.08% -15.01% Year To Date -38.14% -24.85%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2420 Brunello Trace - Lutz,FL 33558 USA ph: 800-261-0281 fax: 800-265-6932 ir@trxade.com http://www.trxade.com

• General Corporate Information    Officers Suren Ajjarapu - Chairman and Chief Executive Officer Prashant Patel - President and Chief Operating Officer Howard A. Doss - Chief Financial Officer Donald G. Fell - Director Charles L. Pope - Director Peer Information TRxADE HEALTH, Inc. (CHCR) TRxADE HEALTH, Inc. (ESRX) TRxADE HEALTH, Inc. (MYDP) TRxADE HEALTH, Inc. (GBCS) TRxADE HEALTH, Inc. (LAXAF) TRxADE HEALTH, Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 89846A207 SIC: 5122 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/25/22 Share - Related Items Shares Outstanding: 8.18 Most Recent Split Date: 2.00 (0.17:1) Beta: 1.36 Market Capitalization: $11.94 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.32 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 20.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/25/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.14 Price/Cash Flow: - Price / Sales: 1.19 EPS Growth vs. Year Ago Period: -50.00% vs. Previous Quarter: -33.33% Sales Growth vs. Year Ago Period: 6.13% vs. Previous Quarter: 35.68% ROE 03/31/22 - -73.00 12/31/21 - -50.16 09/30/21 - -63.53 ROA 03/31/22 - -51.87 12/31/21 - -40.27 09/30/21 - -54.35 Current Ratio 03/31/22 - 2.25 12/31/21 - 4.72 09/30/21 - 7.92 Quick Ratio 03/31/22 - 2.08 12/31/21 - 4.66 09/30/21 - 7.78 Operating Margin 03/31/22 - -30.91 12/31/21 - -28.38 09/30/21 - -45.64 Net Margin 03/31/22 - -55.82 12/31/21 - -53.76 09/30/21 - -72.07 Pre-Tax Margin 03/31/22 - -55.88 12/31/21 - -53.76 09/30/21 - -72.04 Book Value 03/31/22 - 0.35 12/31/21 - 0.46 09/30/21 - 0.57 Inventory Turnover 03/31/22 - 38.13 12/31/21 - 27.06 09/30/21 - 11.94 Debt-to-Equity 03/31/22 - 0.12 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 10.34 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©